NCT03979651
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03979651
Title MEK and Autophagy Inhibition in Metastatic/Locally Advanced, Unresectable Neuroblastoma RAS (NRAS) Melanoma (CHLOROTRAMMEL)
Acronym CHLOROTRAMMEL
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Hospices Civils de Lyon
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
CHU Estaing Clermont-Ferrand Clermont Ferrand 63003 France Details
CHU Grenoble Alpes La Tronche La Tronche 38700 France Details
AP-HP_HOPITAL Saint Louis Paris Paris 75010 France Details
Centre Hospitalier Lyon Sud Lyon Pierre-Bénite 69310 France Details
INSTITUT Claudius Rigaud Toulouse Toulouse 31000 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field